How should I evaluate and manage renal function in a patient with low serum creatinine, high eGFR, reduced muscle mass from chronic low‑protein intake, hypercalciuria, brushite kidney stones, and who is taking potassium citrate?

Evaluation and Management of Low Creatinine with High eGFR

In a patient with low serum creatinine and high eGFR due to reduced muscle mass from chronic low-protein intake, you should measure serum cystatin C and calculate eGFRcys or eGFRcr-cys to obtain an accurate assessment of true kidney function, as the creatinine-based eGFR is falsely elevated and unreliable in this clinical context. 1

Why the Standard eGFR is Inaccurate Here

Your patient's low-protein diet is a non-GFR determinant of serum creatinine that makes eGFRcr systematically inaccurate 1. The reduced muscle mass from chronic protein restriction generates less creatinine, artificially lowering serum creatinine and falsely elevating the calculated eGFR 2, 3. This creates a dangerous scenario where the eGFR suggests excellent kidney function when true GFR may be substantially lower.

The 2024 KDIGO guidelines explicitly identify low-protein diets as situations where standard creatinine-based estimates fail 1. Research confirms that eGFR error correlates strongly with lean muscle mass (r=-0.350, P<0.001), with eGFR falsely reduced by -5.9 ± 1.4 mL/min per 10 kg lean mass 2. In your patient's case, this relationship works in reverse—low muscle mass falsely elevates the eGFR.

The Recommended Approach

Step 1: Measure Cystatin C

Order serum cystatin C and calculate eGFRcys (cystatin C alone) rather than eGFRcr-cys (combined formula) 1. The KDIGO guidelines specifically state: "Consider eGFRcys rather than eGFRcr-cys in otherwise healthy populations with decreased creatinine generation due to reduced muscle mass" 1.

This is critical because:

• Cystatin C is not affected by muscle mass or dietary protein intake 1
• eGFRcys is appropriate when no comorbid illness exists other than reduction in muscle mass 1
• The combined eGFRcr-cys formula would still be contaminated by the inaccurate creatinine component

Step 2: If Greater Accuracy is Needed

If clinical decisions depend on precise GFR measurement (such as medication dosing or determining if true kidney disease exists), measure GFR using plasma clearance of an exogenous filtration marker 1. This is the gold standard when eGFR formulas are unreliable.

Managing the Kidney Stone Disease

Continue Potassium Citrate Appropriately

Your patient is correctly on potassium citrate for brushite (calcium phosphate) stones with hypercalciuria 4. The FDA labeling demonstrates efficacy in reducing stone formation rates in hypocitraturic calcium nephrolithiasis 4.

However, be aware of a critical caveat: Potassium citrate increases urinary pH, phosphate, and oxalate levels, which paradoxically increases calcium phosphate supersaturation despite lowering urinary calcium 5. In brushite stone formers specifically, this pH elevation may not be entirely beneficial. Monitor 24-hour urine parameters to ensure the treatment is achieving the desired effect.

Address the Nutritional Component

The chronic low-protein intake causing reduced muscle mass requires careful evaluation:

• Assess for protein-energy malnutrition, which correlates with morbidity and mortality 6
• Consider whether the protein restriction is medically necessary or excessive
• If true kidney disease is confirmed by cystatin C-based eGFR, protein restriction may be appropriate, but muscle mass preservation remains essential 6

Monitor Hypercalciuria

The hypercalciuria driving stone formation may be influenced by multiple factors that interact with kidney function 7:

• Age, weight, and serum 25(OH)D indirectly affect urinary calcium
• Serum PTH and creatinine directly affect urinary calcium excretion
• 24-hour urinary sodium, urea, and citrate have direct effects

Common Pitfalls to Avoid

1. Do not trust the high eGFRcr in this patient—it is systematically biased upward by low muscle mass 2, 8

2. Do not use eGFRcr-cys (the combined formula) as your confirmatory test—use eGFRcys alone, since the patient has no comorbid illness beyond reduced muscle mass 1

3. Do not assume potassium citrate is universally beneficial for calcium phosphate stones—it may increase supersaturation despite lowering calcium 5

4. Do not overlook the nutritional implications of chronic low-protein intake—muscle wasting affects quality of life and mortality 6, 3

5. Recognize that diagnostic accuracy is worst at extremes—in patients with cachexia, eGFR has only 68.4% sensitivity for detecting true kidney disease 2

Clinical Decision Algorithm

Low creatinine + High eGFRcr + Reduced muscle mass from low-protein diet
↓
Order serum cystatin C
↓
Calculate eGFRcys (NOT eGFRcr-cys)
↓
Is eGFRcys normal (>60 mL/min/1.73m²)?
├─ YES → True kidney function is normal
│         Continue potassium citrate
│         Address nutritional status
│         Monitor 24-hour urine parameters
│
└─ NO → True kidney disease exists
          Consider measured GFR if precise staging needed
          Adjust medications for true GFR
          Reassess protein restriction appropriateness